Skip to Content
Home > Care & Treatment > Payson Center for Cancer Care > Clinical Trials > Clinical Trials Search Results
A Randomized Phase II Trial of Neoadjuvant Cisplatin vs Doxorubicin/Cyclophosphamide (AC) in Women with Newly Diagnosed Breast Cancer and Germline BRCA Mutations
Studying early surgery to see how well it works compared to standard palliative therapy in treating patients with stage IV breast cancer.
For patients with early stage triple negative breast cancer.
Alternate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant Treatment (ALTERNATE) in postmenopausal women:
Comparing Gemcitabine, Cisplatin and Avastin to Gemcitabine, Cisplatin and Placebo in Patients With Advanced Transitional Cell Cancer
To determine if patients with renal cancer treated with Cabozantinib will have longer period of time with tumor growth compared to patients treated with Sunitinib.
To determine if the addition of Armodafinil will help reduce patient's reported fatigue associated with chemotherapy and radiation therapy.
Patients with advanced non-small cell lung cancer whose tumor’s have high levels of COX-2 may be eligible for this study. The purpose of the study is to see if adding celecoxib versus placebo to standard chemotherapy has any benefit.
The study will compare the effects of hormone therapy and chemotherapy before surgery compared to just surgery alone.
© 2015 Concord Hospital